Nuvo Pharmaceuticals Inc MRVFF

Healthcare Drug Manufacturers - Specialty & Generic

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.

OTCQX:MRVFF - Post by User

Nuvo Pharmaceuticals Inc > Market cap only 5.3M

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Oct 31, 2019 9:37am

121 Views

Post# 30291165

RE:Market cap only 5.3M

But enterprise value = $112 million.

debt... $126 mil.
cash...$18 mil.
mkt cap...$4.5 mil.

midard wrote: · Third Quarter Adjusted Total Revenue - $18.9 million and $55.1 million year-to-date ·
· Third Quarter Adjusted EBITDA - $7.8 million and $18.7 million year-to-date ·
· Third Quarter Gross Profit - $11.3 million and $30.0 million year-to date ·